A new study suggests that popular weight loss drugs may reduce the risk of suicide in adolescents. KYW medical editor Dr. Brian McDonough has more.

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

WHILE the price of the same medication may be expensive in one pharmacy and very cheap in another, it may not be as a result ...

Most patients still need to be managed by oral medications to treat diabetes and not injections, at least in the early stages ...

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

The myth of ‘big-boned’ continues to this day, leading to many unhealthy habits, practices, and lifestyles among the ...

Semaglutide, a GLP-1 agonist, has been widely studied due to its versatility, efficacy, and ability to address multiple ...

MariTide is being studied for the treatment of obesity and Type 2 diabetes and demonstrated weight loss at 52 weeks.

Tom Nolan reviews this week’s research Many people with osteoporosis are unable to tolerate oral bisphosphonates—many others would prefer a six monthly denosumab injection to a once weekly pill that ...

A SYSTEMATIC review investigating the impact of glucagon-like peptide-1 receptor agonists on alcohol consumption has yielded ...